Y. Mouton

发表

Introduction of SARS in France, March–April, 2003

Bruno Hoen, Yves Mouton, Sylvie van der Werf, 2004, Emerging infectious diseases.

Acute respiratory distress syndrome and severe acute respiratory syndrome: circulating interleukin 4 level could be a marker

Y. Yazdanpanah, B. Guery, J. Dessaint, 2004, Médecine et Maladies Infectieuses.

Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis.

Y. Yazdanpanah, É. Senneville, L. Dubreuil, 2001, The Journal of antimicrobial chemotherapy.

Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study.

Y. Yazdanpanah, H. Migaud, É. Senneville, 2006, Clinical therapeutics.

Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.

Y. Yazdanpanah, A. Goffard, Y. Mouton, 2003, The Journal of antimicrobial chemotherapy.

Associations d'anti-rétroviraux

Y. Mouton, Eric Senneville, C. Beuscart, 1994 .

Discordant effects of interleukin‐2 on viral and immune parameters in human immunodeficiency virus‐1‐infected monocyte‐derived mature dendritic cells

G. Bahr, Y. Mouton, E. Darcissac, 2003, Clinical and experimental immunology.

Isolated cutaneous Mycobacterium avium complex infection in AIDS

C. Chidiac, É. Senneville, S. Alfandari, 1997, International journal of dermatology.

Cytokine Analysis at the Single Cell Level and Lymphoproliferative Responses to Mycobacterial Antigens in HIV-1 Patients with Successful Virologic Response to Potent Antiretrovirals

Mahavir Singh, A. Capron, G. Rook, 2000, Journal of Clinical Immunology.

Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression.

A. Capron, G. Bahr, M. Loyens, 1999, The Journal of infectious diseases.

High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients

D. Hober, D. Groote, Y. Mouton, 1996, Infection.

A Microassay for Determination of the Cytopathogenicity of Human Immunodeficiency Virus Type‐1 Isolates

D. Hober, Y. Mouton, L. Shen, 1996, Microbiology and immunology.

Safety of Prolonged High-Dose Levofloxacin Therapy for Bone Infections

Y. Yazdanpanah, H. Migaud, J. Poissy, 2007, Journal of chemotherapy.

Is PCR a useful tool for the diagnosis of tuberculosis in 1995?

J. Grosset, Y. Mouton, 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units].

A. Philippon, C. Socolovsky, F. Fourrier, 1990, Presse medicale.

Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.

Y. Mouton, C. Beuscart, 1995, The Journal of antimicrobial chemotherapy.

Role of nitric oxide in the regulation of lymphocyte apoptosis and HIV-1 replication.

A. Capron, T. Idziorek, G. Bahr, 1997, International journal of immunopharmacology.

Linezolid-induced neuropathy.

Y. Yazdanpanah, É. Senneville, Y. Mouton, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1.

D. Hober, C. Chidiac, M. Assicot, 1997, The Journal of infection.

Bacterial infections in hospitalized HIV patients

Y. Yazdanpanah, B. Guery, C. Chidiac, 1998 .

Infections bactriennes chez les patients infects par le VIH : l'exprience du CISIH France-Nord

É. Senneville, Y. Mouton, S. Alfandari, 1994 .

Gram-negative nosocomial infection: incidence, pathogens, compromised host.

Y. Mouton, O. Leroy, C. Beuscart, 1988, British journal of clinical practice. Supplement.

In HIV-1-infected patients, plasma levels of HIV-1 RNA are inversely correlated with IFN-alpha responsiveness of whole-blood cultures to sendai virus.

D. Hober, G. Lion, S. Chabou, 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens

Y. Mouton, C. Chidiac, 2005, Infection.

Rat bite fever mimicking rheumatoid arthritis

D. Mulleman, É. Senneville, Y. Mouton, 2005, Scandinavian journal of infectious diseases.

Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment.

Y. Yazdanpanah, G. Bahr, D. Sissoko, 2003, The Journal of antimicrobial chemotherapy.

The Synthetic Immunomodulator Murabutide Controls Human Immunodeficiency Virus Type 1 Replication at Multiple Levels in Macrophages and Dendritic Cells

G. Bahr, Y. Mouton, A. Capron, 2000, Journal of Virology.

Tolerance, compliance and psychological consequences of post-exposure prophylaxis in health-care workers

É. Senneville, S. Alfandari, Y. Mouton, 1998, International journal of STD & AIDS.

Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures.

Y. Yazdanpanah, H. Melliez, É. Senneville, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nosocomial infections associated with long-term radial artery cannulation

C. Chidiac, Y. Mouton, O. Leroy, 2004, Intensive Care Medicine.

Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity.

A. Capron, D. Hober, A. Haque, 1989, Clinical and experimental immunology.

ABCB1 Allele Polymorphism Is Associated with Virological Efficacy in Naïve HIV-Infected Patients on HAART Containing Nonboosted PIs But Not Boosted PIs

Y. Yazdanpanah, H. Melliez, F. Broly, 2008, HIV clinical trials.

Soluble CD23 in Human Immunodeficiency Virus Type 1 Infected Patients

D. Hober, P. Lobert, Y. Mouton, 1993, Microbiology and immunology.

A decreased production of IL12 in vitro is associated with isolation of cytopathic HIV‐1 strains in HIV‐1‐infected patients

D. Hober, D. de Groote, G. Lion, 1998, Journal of medical virology.

[Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].

D. Sissoko, Y. Mouton, X. de la Tribonnière, 2000, Presse medicale.

Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.

F. Barré-Sinoussi, T. Idziorek, M. Mehtali, 1994, Proceedings of the National Academy of Sciences of the United States of America.

In vitro antibiotics testing and its relationship to clinical activity.

L. Dubreuil, Y. Mouton, 1997, Journal of chemotherapy.

Suspected SARS patients hospitalised in French isolation units during the early SARS epidemic: the French experience.

B. Issartel, D. Peyramond, C. Chidiac, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis

D. Hober, M. Assicot, C. Bohuon, 1995, Infection.

Failure of intravenous antibiotic therapy of multiple temporal brain abscesses due to Propionibacterium acnes requiring temporal lobectomy.

C. Chidiac, O. Lamy, É. Senneville, 1997, The Journal of infection.

Elevated serum level of Fas ligand correlates with the asymptomatic stage of human immunodeficiency virus infection.

A. Capron, G. Bahr, M. Tanaka, 1997, Blood.

Imported malaria: presentation and outcome of 111 cases.

C. Chidiac, É. Senneville, S. Alfandari, 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

R&D Highlights from the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy

Y. Mouton, 1997 .

[Management of community-acquired lower respiratory tract infection in the adult. Recommendations by the French Language Society of Pneumology with collaboration of the French Language Society of Infectious Pathology, from the recommendations of the European Respiratory Society].

N. Roche, Y. Mouton, G. Huchon, 1999, Revue des maladies respiratoires.

News on HIV therapies from the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy

Y. Mouton, 1997 .

Plasma levels of sTNFR p75 and IL-8 in patients with HIV-1 infection.

D. Hober, D. de Groote, Y. Mouton, 1996, Immunology letters.

[Effectiveness and tolerance of piperacillin in 333 patients].

C. Soussy, Y. Mouton, C. Beuscart, 1986, Presse medicale.

Bilateral ureteral obstruction due to Saccharomyces cerevisiae fungus balls.

C. Chidiac, É. Senneville, S. Alfandari, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients.

C. Chidiac, É. Senneville, Y. Mouton, 1990, The Journal of antimicrobial chemotherapy.

Haemorrhagic Ulcerative Colitis Due to Isospora Belli in AIDS

C. Chidiac, É. Senneville, S. Alfandari, 1995, International journal of STD & AIDS.

Diabetes mellitus following treatment of AIDS with didanosine.

C. Chidiac, S. Alfandari, Y. Mouton, 1995, AIDS.

Melioidotic osteomyelitis of the femur occurring in a traveler.

Y. Yazdanpanah, É. Senneville, L. Dubreuil, 2002, Journal of travel medicine.

Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.

Y. Yazdanpanah, H. Migaud, É. Senneville, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.

Y. Yazdanpanah, H. Migaud, F. Giraud, 2004, The Journal of antimicrobial chemotherapy.

Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy

Y. Yazdanpanah, C. Maurage, B. Sablonnière, 2000, AIDS.

Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials

M. Zwahlen, M. Egger, Y. Yazdanpanah, 2004, BMJ : British Medical Journal.

Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.

P. Lecocq, C. Chidiac, É. Senneville, 1993, The Journal of antimicrobial chemotherapy.

[Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].

C. Chidiac, É. Senneville, Y. Mouton, 1990, Pathologie-biologie.

Persistent antibody response to the HIV-1-negative regulatory factor in HIV-1-infected seronegative persons.

B. Guy, A. Capron, S. Chamaret, 1989, The New England journal of medicine.

Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

A. Capron, D. Monté, G. Torpier, 1992, The Journal of experimental medicine.

Co-trimoxazole for toxic epidermal necrolysis in AIDS

P. Lecocq, C. Chidiac, É. Senneville, 1991, The Lancet.

Pneumonies experimentales a bacilles a gram negatif

C. Chidiac, Y. Mouton, G. Beaucaire, 1989 .

Bidimensional retinal blood vessel reconstruction by a new color edge tracking procedure

Ludovic Macaire, Jack-Gérard Postaire, V. Rakotomalala, 1998, 1998 IEEE Southwest Symposium on Image Analysis and Interpretation (Cat. No.98EX165).

Improved aero-anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow's broth

Y. Yazdanpanah, H. Migaud, R. Courcol, 2006, Acta orthopaedica.

Granulocyte‐Macrophage Colony‐Stimulating Factor and Tumor Necrosis Factor Alpha in Patients with Human Immunodeficiency Virus (HIV) Type 1 Infection

D. Hober, Y. Mouton, M. Caillaux, 1993, Microbiology and immunology.

Variations in serum IL‐7 and 90K/Mac‐2 binding protein (Mac−2 BP) levels analysed in cohorts of HIV‐1 patients and correlated with clinical changes following antiretroviral therapy

G. Bahr, Y. Mouton, X. de la Tribonnière, 2001, Clinical and experimental immunology.

Soluble tumor necrosis factor receptor type II (sTNFRII) in HIV-infected patients: relationship with the plasma level of HIV-1 RNA.

D. Hober, D. de Groote, G. Lion, 1999, Immunology letters.

Antibodies to the nef protein and to nef peptides in HIV-1-infected seronegative individuals.

B. Guy, B. Mach, M. Kieny, 1989, AIDS research and human retroviruses.

[Morbidity and cost of rotavirus infections in France].

Y. Yazdanpanah, H. Melliez, P. Boelle, 2005, Médecine et maladies infectieuses.

Infectious complications of corticosteroids as adjuvant treatment of Pneumocystis carinii pneumonia

C. Chidiac, É. Senneville, S. Alfandari, 1996 .

Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.

R. Salamon, K. Freedberg, Y. Yazdanpanah, 2001, International journal of epidemiology.

A phase I study of a six-week cycle of immunotherapy with Murabutide in HIV-1 patients naive to antiretrovirals.

G. Bahr, D. Sissoko, Y. Mouton, 2003, Medical science monitor : international medical journal of experimental and clinical research.

Selective Regulation of Human Immunodeficiency Virus-Infected CD4+ Lymphocytes by a Synthetic Immunomodulator Leads to Potent Virus Suppression In Vitro and in hu-PBL-SCID Mice

G. Bahr, Y. Mouton, A. Capron, 2001, Journal of Virology.

Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.

B. Marchou, J. Reynes, M. Micoud, 1994, Journal of acquired immune deficiency syndromes.

Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: the case of Nigeria.

Y. Yazdanpanah, P. Böelle, H. Melliez, 2007, Vaccine.

Clinical Tolerance and Immunologic Effects After Single or Repeated Administrations of the Synthetic Immunomodulator Murabutide in HIV‐1‐Infected Patients

G. Bahr, Y. Mouton, X. de la Tribonnière, 2002 .

Impact of protease inhibitors on AIDS‐defining events and hospitalizations in 10 French AIDS reference centres

P. Massip, J. Lang, P. Dellamonica, 1997, AIDS.

Lifetime Cost of HIV Care in France during the Era of Highly Active Antiretroviral Therapy

M. Weinstein, R. Salamon, K. Freedberg, 2001, Antiviral therapy.

Impact of measles in France.

Y. Mouton, M. Rey, R. Netter, 1983, Reviews of infectious diseases.

Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?

R. Salamon, K. Freedberg, Y. Yazdanpanah, 1999, The Lancet.

Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis.

M. Weinstein, R. Salamon, K. Freedberg, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Are the principles of treatment of chronic osteitis applicable to the diabetic foot?].

Y. Yazdanpanah, É. Senneville, L. Dubreuil, 2002, Presse medicale.

In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms

L. Dubreuil, Y. Mouton, J. Rossignol, 1996, Antimicrobial agents and chemotherapy.

A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis.

A. Masquelier, C. Chidiac, Y. Mouton, 1992, The American journal of medicine.

Impact of Human Immunodeficiency Virus Type 1 Subtype on First-Line Antiretroviral Therapy Effectiveness

Y. Yazdanpanah, A. Goffard, A. Chéret, 2005, Antiviral therapy.

[Pneumonia caused by Gram-negative bacilli].

Y. Mouton, G. Beaucaire, A. Fourrier, 1983, La Revue du praticien.

Mice Suppression In Vitro and in hu-PBL-SCID Immunomodulator Leads to Potent Virus Lymphocytes by a Synthetic + Immunodeficiency Virus-Infected CD 4 Selective Regulation of Human

A. Capron, G. Bahr, Y. Mouton, 2001 .

Analysis of Costs Attributable to an Outbreak of Severe Acute Respiratory Syndrome at a French Hospital

Y. Yazdanpanah, B. Dervaux, X. Lenne, 2006, Infection Control & Hospital Epidemiology.

Chronic myelogenous leukemia in an HIV-Infected patient

J. Jouet, I. Plantier, S. Alfandari, 1998, Infection.

Incidence rate and risk factors for loss to follow‐up in a French clinical cohort of HIV‐infected patients from January 1985 to January 1998

Y. Yazdanpanah, B. Lebouché, D. Sissoko, 2006, HIV medicine.

Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection.

Y. Yazdanpanah, S. Depil, O. Moralès, 2007, Vaccine.

Activation-Induced Death by Apoptosis in CD4 T Cells from HIV-Infected Asymptomatic Individuals

A. Capron, D. Monté, G. Torpier, 1991 .

Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment.

Y. Yazdanpanah, B. Hoen, F. Lescure, 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.

H. Lode, E. Bouza, W. Wilson, 1997, Journal of chemotherapy.

Rickettsia conorii isolated from ticks introduced to northern France by a dog

P. Lecocq, C. Chidiac, É. Senneville, 1991, The Lancet.

Hepatitis C virus co‐infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus‐positive patients

Rey, L. Cuzin, D. Peyramond, 2000, Journal of viral hepatitis.

A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication.

A. Capron, G. Bahr, Y. Mouton, 2003, The Journal of general virology.

Clinical tolerance and immunologic effects after single or repeated administrations of the synthetic immunomodulator murabutide in HIV-1-infected patients.

G. Bahr, Y. Mouton, X. de la Tribonnière, 2002, Journal of acquired immune deficiency syndromes.

Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimen.

Y. Yazdanpanah, C. Rabaud, Y. Mouton, 2007, AIDS.

Broad- versus narrow-spectrum antibiotic use: the role of in vitro testing and its correlation with clinical efficacy.

É. Senneville, Y. Mouton, 1992, Postgraduate medical journal.